These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29942131)

  • 1. Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial.
    Che T; Teng X; Huang Q; Mu Y; Tang X; Mu X; Wei Y
    Neuropsychiatr Dis Treat; 2018; 14():1527-1533. PubMed ID: 29942131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine.
    Liang Z; Jia Y; Zhao L; Zhu R; He X; Tong B; Yang F; Hao L; Cui P; Yuan J
    Aging (Albany NY); 2021 Oct; 13(19):22934-22946. PubMed ID: 34610580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease.
    Chen JW; Xie SQ
    Neuropsychiatr Dis Treat; 2018; 14():547-552. PubMed ID: 29497298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial.
    Kang R; He Y; Yan Y; Li Z; Wu Y; Guo X; Liang Z; Jiang J
    Neuropsychiatr Dis Treat; 2015; 11():1307-11. PubMed ID: 26064049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine.
    Stein DJ
    Neurol Ther; 2023 Apr; 12(Suppl 1):13-19. PubMed ID: 37115460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.
    Henigsberg N; Mahableshwarkar AR; Jacobsen P; Chen Y; Thase ME
    J Clin Psychiatry; 2012 Jul; 73(7):953-9. PubMed ID: 22901346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.
    Karaiskos D; Tzavellas E; Ilias I; Liappas I; Paparrigopoulos T
    Int J Clin Pract; 2013 Mar; 67(3):257-60. PubMed ID: 23409693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Behavior Therapy as Augmentation for Sertraline in Treating Patients with Persistent Postural-Perceptual Dizziness.
    Yu YC; Xue H; Zhang YX; Zhou J
    Biomed Res Int; 2018; 2018():8518631. PubMed ID: 29707579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial.
    Kashani L; Eslatmanesh S; Saedi N; Niroomand N; Ebrahimi M; Hosseinian M; Foroughifar T; Salimi S; Akhondzadeh S
    Pharmacopsychiatry; 2017 Mar; 50(2):64-68. PubMed ID: 27595298
    [No Abstract]   [Full Text] [Related]  

  • 13. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
    Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
    CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Depression in Diabetes Mellitus: A Multicentric Randomized Controlled Trial Comparing Effectiveness of Fluoxetine and Mindfulness in Primary Care: Protocol for DIAbetes Mellitus ANd Depression (DIAMAND) Study.
    Chandra M; Raveendranathan D; Johnson Pradeep R ; Patra S; Rushi ; Prasad K; Brar JS
    Indian J Psychol Med; 2020 Dec; 42(6 Suppl):S31-S38. PubMed ID: 33487800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2006 Jun; 51(7):453-60. PubMed ID: 16838827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
    Zhang WJ; Yang XB; Zhong BL
    J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder.
    Huang J; Xie XM; Lyu N; Fu BB; Zhao Q; Zhang L; Wang G
    Front Psychiatry; 2023; 14():1115008. PubMed ID: 37151978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy.
    Bellino S; Rinaldi C; Bogetto F
    Can J Psychiatry; 2010 Feb; 55(2):74-81. PubMed ID: 20181302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.
    Shahmansouri N; Farokhnia M; Abbasi SH; Kassaian SE; Noorbala Tafti AA; Gougol A; Yekehtaz H; Forghani S; Mahmoodian M; Saroukhani S; Arjmandi-Beglar A; Akhondzadeh S
    J Affect Disord; 2014 Feb; 155():216-22. PubMed ID: 24289892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials.
    Chen Y; Li J; Liao M; He Y; Dang C; Yu J; Xing S; Zeng J
    Int Clin Psychopharmacol; 2024 May; 39(3):163-173. PubMed ID: 37781768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.